--- eventsindex_id: EI-00882 slug: biotechx-europe title: BIOTECHX EUROPE title_alt: - BioTechX - BioTechX Basel canonical_url: https://eventsindex.org/events/biotechx-europe.html next_edition_dates: 2026-10-06 to 2026-10-08 next_edition_year: 2026 date_start: '2026-10-06' date_end: '2026-10-08' venue: Messe Basel city: Basel country: Switzerland organiser: Terrapinn Holdings Ltd organiser_url: https://www.terrapinn.com/conference/biotechx/index.stm b2b: true vector: sector: - digital-health audience: - trade-public format: - conference purpose: - networking geography_scope: - Western-Europe season: autumn meta_description: 'BioTechX Europe 2026 in Basel, 6-8 October: Europe''s largest congress on data, AI and genomics in pharma R&D, from drug discovery to clinical AI.' editorial_take: 'BioTechX Europe is the technical meeting point for data and AI practitioners inside pharma: not a deal-making congress but a working forum where R&D data teams from Novartis, Roche and their peers argue out drug-discovery AI, bioinformatics and genomics across three days in Basel.' generated_by: enrich-cowork (N1/N2/N3) last_verified: '2026-06-30' schema_version: v8.0 language: en --- # BioTechX Europe > *A three-day congress in Basel positioned as Europe's largest event covering data, AI and genomics in pharma and healthcare, where research and development data teams from the major pharmaceutical companies work through drug-discovery AI, bioinformatics, real-world evidence and clinical machine learning.* --- ## Quick Facts | DATES | VENUE | ORGANISER | ATTENDANCE | |---|---|---|---| | 6–8 October 2026 | Messe Basel | Terrapinn Holdings Ltd | ~3,000 (organiser figure) | ## Definition BioTechX Europe is an annual congress held at Messe Basel, dedicated to the application of data, artificial intelligence and genomics across pharmaceutical research and development. The programme runs technical tracks covering AI in drug discovery, large language models in pharma, bioinformatics, real-world evidence, AI in clinical trials and multi-omics, drawing roughly 3,000 participants, around 400 speakers and 150 exhibitors. It is organised by Terrapinn and sits deliberately at the intersection of computational science and pharmaceutical R&D rather than clinical medicine or commercial deal-making. ## What BioTechX Europe covers and who it is for BioTechX addresses the data and AI layer inside pharmaceutical research, the part of the value chain where drug discovery, clinical development and genomics meet machine learning. It is built for the people who do that work and the executives who sponsor it: R&D data scientists, bioinformaticians, AI and machine-learning engineers, genomics specialists and the chief data and digital officers above them. The science on stage is computational and infrastructural, covering model architectures, data integration and laboratory automation, rather than clinical outcomes, which sets it apart from both medical congresses and digital health investor forums. ## Who attends BioTechX Europe - Pharmaceutical R&D executives and chief data officers - Bioinformaticians and computational biologists - AI and machine-learning engineers working in drug discovery - Genomics and multi-omics specialists - Clinical informaticists and digital health product teams - Investors and corporate development teams in life sciences - Technology and data-infrastructure vendors serving pharma ## What BioTechX Europe covers programmatically The programme is organised across hubs and thematic tracks: - **AI in drug discovery and development**: model-driven target identification, generative chemistry, foundation models - **Large language models in pharma**: agentic AI, knowledge graphs and semantic technologies - **Data management and architecture**: FAIR data principles, data integration, infrastructure - **Real-world data and evidence**: secondary use of health data in development - **AI in clinical trials**: trial design, recruitment and operations - **Bioinformatics and in-silico R&D**: cheminformatics, multi-omics, digital twins - **AI for imaging and federated learning**: privacy-preserving model training across institutions ## Programme tracks and special formats The congress is structured around themed hubs, including a Healthcare 4.0 Hub, a Discovery Disrupted Hub and a Data Unleashed Hub, alongside roundtables and an exhibition of data and AI vendors serving the sector. ## Notable speakers Speakers are drawn mainly from the data and AI functions of the major pharmaceutical companies: - **Christian Diehl**, Chief Data & Digital Officer Biomedical Research, Novartis - **Yuliya Bohdan**, Global AI Product Owner, Roche - **Nikolina Nakic**, Head of Digital Biology, AI & Digital Innovation, Novo Nordisk - **Sakshi Gulati**, Senior Director, AI for Science Innovation, AstraZeneca - **Rolf Jautelat**, VP R&D Data Science & AI, Bayer ## FAQ · Identity and audience ### Is BioTechX a clinical or a technical event? Technical. The programme is built around data science, AI and genomics in pharmaceutical R&D, with sessions on model architectures, bioinformatics and laboratory automation. Clinicians attend, but the centre of gravity is computational rather than clinical practice. ### How does it differ from MEDICA or HLTH Europe? MEDICA is a broad medical-device and diagnostics trade fair; HLTH Europe targets digital health executives, payers and investors. BioTechX is narrower and deeper, aimed at the R&D data teams inside pharma and their chief data officers, with hands-on tracks in bioinformatics, cheminformatics and large language models that neither of the others runs at this depth. ### Who is BioTechX NOT designed for? - Medical device manufacturers seeking a hardware sourcing floor - Commercial and market-access functions without an R&D data remit - Clinicians attending for continuing medical education - Generalist AI professionals with no life-sciences connection - Teams focused on consumer digital health or wellness products ## The venue: Messe Basel BioTechX Europe is held at Messe Basel (MCH Messe Basel), in the centre of the Swiss pharmaceutical hub. Basel hosts the headquarters of several major pharmaceutical companies, which reinforces the event's positioning as a regional meeting point for pharma R&D and data teams. ## The organiser: Terrapinn Holdings Ltd Terrapinn is a global business-to-business event company specialising in life sciences, financial services and technology, headquartered in the United Kingdom. It runs the BioTechX congresses in Europe and the United States and operates a portfolio of life-sciences and technology events. BioTechX evolved from the earlier BioData World Congress, rebranding to its current name in 2022. --- ## Editorial take *BioTechX Europe is the technical meeting point for data and AI practitioners inside pharma: not a deal-making congress but a working forum where R&D data teams from Novartis, Roche and their peers argue out drug-discovery AI, bioinformatics and genomics across three days in Basel.* ## How to register and what it costs Registration is handled through the official Terrapinn event page. Conference passes start from 2,495 EUR, and free passes are available to qualifying pharmaceutical and biotechnology companies via application. The early-bird deadline for 2026 has passed as of verification. ## FAQ · Access and practicalities ### Where is BioTechX Europe held? At Messe Basel (MCH Messe Basel), Messeplatz, Basel, Switzerland. ### Can pharma and biotech staff attend for free? Yes, qualifying pharmaceutical and biotechnology delegates can apply for complimentary passes; standard conference passes start from 2,495 EUR. ### Is the programme more about AI or about genomics? Both are structural. The congress self-describes as covering data, AI and genomics together, with dedicated tracks for AI in drug discovery, bioinformatics and multi-omics running in parallel. ## Resources | Resource | URL | |---|---| | Official website | https://www.terrapinn.com/conference/biotechx/index.stm | | Register | https://www.terrapinn.com/conference/biotechx/index.stm | | Organiser | https://www.terrapinn.com | --- **Last verified:** 2026-06-30 **Next review:** 2026-07-30 **Notes:** Edition number not publicly stated; event rebranded from BioData World Congress in 2022. Attendance, speaker and exhibitor figures are organiser-reported. **Variables:** N/58 **Concept definition:** not applicable